Tetra Tech (TTEK) upgraded at BMO from Market Perform to Outperform, BMO Capital said. $30 price target. Company should see an improving order cycle, given more faster-growing private clients.
STOCK COMMENTS / EPS CHANGESApple (AAPL) target raised at Needham to $620. iPad popularity is also driving Mac sales.
Agrium (AGU) estimates, target boosted at Goldman. Shares of AGU now seen reaching $85, according to Goldman Sachs. Estimates also upped, as the company is seeing higher retail demand. Neutral rating.
Akamai Technologies (AKAM) target raised at Jefferies. Shares of AKAM now seen reaching $41, Jefferies said. Holiday / traffic combine for a very strong fourth quarter. Hold rating.
Akamai estimates, target raised at Credit Suisse. Shares of AKAM now seen reaching $25, according to Credit Suisse. Estimates also increased, to match the company's new guidance. Neutral rating.American Express (AXP) numbers boosted at Morgan Stanley. Shares of AXP now seen reaching $56, according to Morgan Stanley. Estimates also upped, as the company is gaining market share online. Equal-weight rating. Compass Minerals (CMP) numbers cut at Goldman. CMP estimates were reduced through 2013, Goldman Sachs said. Company is being hurt by the mild winter. Sell rating and new $77 price target. Cisco Systems (CSCO - Get Report) numbers upped at Goldman. CSCO estimates were boosted through 2014, Goldman Sachs said. Company is seeing higher sales and cutting costs. Buy rating and new $25 price target. Cisco Systems numbers raised at Oppenheimer. Shares of CSCO now seen reaching $23, Oppenheimer said. Estimates also raised on strong January quarter. Outperform rating. Cisco Systems numbers raised at UBS. Shares of CSCO now seen reaching $24, according to UBS. Estimates also increased on strong 2Q execution. Buy rating. Cognizant (CTSH) estimates, target raised at Goldman. Shares of CTSH now seen reaching $73, according to Goldman Sachs. Estimates also increased, given higher offshore growth. Neutral rating. CVS/Caremark (CVS) numbers raised at Morgan Stanley. Shares of CVS now seen reaching $48, according to Morgan Stanley. Estimates also increased, as the company is gaining market share. Overweight rating. Gildan Activewear (GIL) numbers boosted at Goldman. Shares of GIL now seen reaching $18, according to Goldman Sachs. Estimates also upped, as the company is seeing higher sales. Neutral rating.